Dr. Titilope Fasipe's goals are shaped by her desire to help children facing the hardships of a blood disorder. She is intrigued by the clinical challenges of non-malignant hematologic diseases, where in particular, patients with sickle cell disease continue to have significant co-morbid complications and decreased lifespan. Furthermore, she has long been passionate about the psychosocial barriers to care experienced by children with sickle cell, especially during the transitional years.
In addition to Dr. Fasipe's academic role, she is actively involved in various sickle cell-focused community efforts targeted at understanding these challenges. At the state level, she was appointed to the first Texas Sickle Cell Advisory Committee (2016-2018) by the Executive Commissioner of the Texas Health and Human Services. At the local level, she is the current chair of the Houston Sickle Cell Collaborative - a joint effort between the Houston Health Department and organizations vested in sickle cell disease.
In 202, she was selected as a reviewer of The National Academies of Sciences Engineering Medicine's (NASEM) consensus report on, "Addressing Sickle Cell Disease: A Strategic Plan and Blueprint for Action."
She is board certified by the Texas State Board of Medical Examiners and the American Board of Pediatrics in both pediatrics and pediatric hematology.
Sickle cell disease and other hemoglobinopathies
General hematology conditions